Henry Schein FY2025 EPS Estimate Raised by William Blair

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at William Blair raised their FY2025 earnings per share estimates for shares of Henry Schein in a research note issued to investors on Wednesday, November 5th. William Blair analyst B. Vazquez now expects that the company will post earnings per share of $4.91 for the year, up from their prior forecast of $4.86. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein’s Q4 2025 earnings at $1.29 EPS, Q1 2026 earnings at $1.28 EPS and FY2026 earnings at $5.25 EPS.

HSIC has been the subject of several other reports. Morgan Stanley increased their price objective on Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a research note on Wednesday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a research report on Friday, October 31st. Barrington Research set a $79.00 price target on shares of Henry Schein and gave the company an “outperform” rating in a report on Wednesday. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 price target (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, UBS Group cut their price objective on Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a report on Wednesday, August 6th. Five investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $76.08.

Henry Schein Trading Down 2.7%

Henry Schein stock opened at $70.06 on Friday. The company has a 50 day moving average price of $66.25 and a 200 day moving average price of $68.65. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49. The firm has a market capitalization of $8.50 billion, a price-to-earnings ratio of 22.60, a P/E/G ratio of 2.06 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 4th. The company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS.

Hedge Funds Weigh In On Henry Schein

Several hedge funds have recently bought and sold shares of the business. CYBER HORNET ETFs LLC bought a new position in Henry Schein during the second quarter valued at about $25,000. MUFG Securities EMEA plc acquired a new stake in Henry Schein in the 2nd quarter worth approximately $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in Henry Schein in the 2nd quarter worth approximately $43,000. Steph & Co. bought a new stake in Henry Schein during the second quarter worth approximately $44,000. Finally, CX Institutional grew its holdings in Henry Schein by 107.3% during the second quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after purchasing an additional 337 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.